These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37863339)

  • 21. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
    de Lauretis A; Veeraraghavan S; Renzoni E
    Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a home-based pulmonary rehabilitation program on functional capacity and health-related quality of life in people with interstitial lung disease - A randomized controlled trial protocol.
    Amin R; Maiya GA; Mohapatra AK; Acharya V; Alison JA; Dale M; Vaishali K
    Respir Med; 2022 Sep; 201():106927. PubMed ID: 35964368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
    Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
    Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects.
    Dhooria S; Sehgal IS; Agarwal R; Muthu V; Prasad KT; Kathirvel S; Garg M; Bal A; Aggarwal AN; Behera D
    PLoS One; 2022; 17(7):e0271665. PubMed ID: 35862355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of pulmonary rehabilitation in idiopathic pulmonary fibrosis].
    Vainshelboim B; Kramer MR
    Harefuah; 2012 Apr; 151(4):220-4, 253. PubMed ID: 22616150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the role for nailfold videocapillaroscopy in interstitial lung disease classfication: a systematic review and meta-analysis.
    Umashankar E; Abdel-Shaheed C; Plit M; Girgis L
    Rheumatology (Oxford); 2022 May; 61(6):2221-2234. PubMed ID: 34668513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SINFONIA study protocol: a phase II/III randomised controlled trial examining benefits of guided online group singing in people with chronic obstructive pulmonary disease and interstitial lung disease and their carers.
    Smallwood N; Pascoe A; Vogrin S; Philip J
    Respir Res; 2022 Aug; 23(1):208. PubMed ID: 35974347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
    Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
    Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating lung biomarkers in idiopathic lung fibrosis and interstitial lung diseases associated with connective tissue diseases: Where do we stand?
    Elhai M; Avouac J; Allanore Y
    Semin Arthritis Rheum; 2020 Jun; 50(3):480-491. PubMed ID: 32089354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases.
    Atkins CP; Gilbert D; Brockwell C; Robinson S; Wilson AM
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Aug; 33(2):130-8. PubMed ID: 27537715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms and management of cough in interstitial lung disease.
    Rasheed AZ; Metersky ML; Ghazal F
    Expert Rev Respir Med; 2023 Dec; 17(12):1177-1190. PubMed ID: 38159067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
    Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
    Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
    [No Abstract]   [Full Text] [Related]  

  • 33. Effectiveness of Pulmonary Rehabilitation in Interstitial Lung Disease, Including Coronavirus Diseases: A Systematic Review and Meta-analysis.
    Reina-Gutiérrez S; Torres-Costoso A; Martínez-Vizcaíno V; Núñez de Arenas-Arroyo S; Fernández-Rodríguez R; Pozuelo-Carrascosa DP
    Arch Phys Med Rehabil; 2021 Oct; 102(10):1989-1997.e3. PubMed ID: 33932361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clustering of lung diseases in the family of interstitial lung disease patients.
    Terwiel M; Grutters JC; van Moorsel CHM
    BMC Pulm Med; 2022 Apr; 22(1):134. PubMed ID: 35392870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of antifibrotic therapy on disease progression, all-cause mortality, and risk of acute exacerbation in non-IPF fibrosing interstitial lung diseases: evidence from a meta-analysis of randomized controlled trials and prospective controlled studies.
    Li DY; Liu X; Huang JY; Hang WL; Yu GR; Xu Y
    Ther Adv Respir Dis; 2024; 18():17534666241232561. PubMed ID: 38414439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type D or 'distressed' personality in sarcoidosis and idiopathic pulmonary fibrosis.
    Elfferich MD; De Vries J; Drent M
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):65-71. PubMed ID: 21796893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disease trajectories in interstitial lung diseases - data from the EXCITING-ILD registry.
    Buschulte K; Kabitz HJ; Hagmeyer L; Hammerl P; Esselmann A; Wiederhold C; Skowasch D; Stolpe C; Joest M; Veitshans S; Höffgen M; Maqhuzu P; Schwarzkopf L; Hellmann A; Pfeifer M; Behr J; Karpavicius R; Günther A; Polke M; Höger P; Somogyi V; Lederer C; Markart P; Kreuter M
    Respir Res; 2024 Mar; 25(1):113. PubMed ID: 38448953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical training for interstitial lung disease.
    Holland A; Hill C
    Cochrane Database Syst Rev; 2008 Oct; (4):CD006322. PubMed ID: 18843713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany.
    Maqhuzu PN; Schwarzkopf L; Markart P; Behr J; Holle R; Leidl R; Kreuter M
    Respiration; 2022; 101(11):1015-1023. PubMed ID: 36302347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of characteristics of connective tissue disease-associated interstitial lung diseases, undifferentiated connective tissue disease-associated interstitial lung diseases, and idiopathic pulmonary fibrosis in Chinese Han population: a retrospective study.
    Pan L; Liu Y; Sun R; Fan M; Shi G
    Clin Dev Immunol; 2013; 2013():121578. PubMed ID: 24171031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.